An innovative study is comparing how HIV-positive women respond differently to medication than their male counterparts. The Gender, Race and Clinical Experience (GRACE) study was launched last fall to compare how women and men respond differently to the drug Prezista darunavir) and antiretroviral agents. The groundbreaking study is also exploring racial differences in treatment outcomes. Click to continue at BlackAIDS.org
